Sign in
8-K

Current Report

Protalix BioTherapeutics, Inc. Filed Acc 0001104659-20-032169

Material agreement · Unregistered share sale · Other events

  • Item 1.01 Entry into a material definitive agreement
  • Item 3.02 Unregistered sales of equity securities
  • Item 8.01 Other events

From the SEC's structured data for this filing

Loading tm2012488-1_8k.htm…